Biosynex SA (FR:ALBIO) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Biosynex’s subsidiary, Chembio Diagnostics, has received a $1.5 million grant from the Bill & Melinda Gates Foundation to develop a rapid diagnostic test for congenital syphilis, a growing global health concern. The test aims to offer a quick, accurate, and affordable solution, particularly in low and middle-income regions, enhancing early diagnosis and treatment of syphilis in newborns and pregnant individuals.
For further insights into FR:ALBIO stock, check out TipRanks’ Stock Analysis page.